The U.S. Centers for Disease Control and Prevention will expand its traveler-based surveillance program to include testing for respiratory viruses, partners Ginkgo Bioworks and XWELL said on Monday.
CDC has warned that it expects hospitalizations from COVID-19, RSV infections and flu this year to be similar to last year's numbers, higher than the pre-pandemic levels. The expansion will launch at New York's John F. Kennedy International Airport, San Francisco International Airport, Boston Logan International Airport and Washington Dulles International Airport.